A Comparison of "Second Generation Antipsychotics" in the Treatment for Bipolar Disorder: Focus on Clozapine, Quetiapine, Ziprasidone and Aripiprazole

Bipolar Psychopharmacotherapy: Caring for the Patient

Volumn , Issue , 2006, Pages 125-134

  Keck, Paul E ^a   Mcelroy, Susan L ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Antidepressant activity; Placebo controlled monotherapy; Randomized combination drug trial; Second generation antipsychotics; Thymoleptic activity; Unimodal antimanic effects

Indexed keywords

EID: 80053313609     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470017953.ch8     Document Type: Chapter

References (44)

1. Aprison MH, Takahashi R, Tachiki K (1978) Hypersensitive serotonergic receptors involved in clinical depression-a theory. In Neuropharmacology and Behavior, Haber B, Aprison MH (eds), Plenum, New York, pp. 23-48.
2. Banov MD, Zarate CA, Tohen M, Scialabba D, Wines JD, Kolbrener M, Kim JW, Cole JO (1994) Clozapine therapy in refractory affective disorders: Polarity predicts response in long-term follow-up. J Clin Psychiatry, 55, 295-300.
3. Barbini B, Scherillo P, Benedetti F, Crespi B, Colombo C, Smeraldi E (1997) Response to clozapine in acute mania is more rapid than that of chlorpromazine. Int Clin Psychopharmacol, 12, 109-112.
4. Bourin M, Auby P, Marcus RN, Swanik R, McQuade RD, Iwamoto T, Sanchez R (2003) Aripiprazole versus haloperidol for maintained treatment effect of acute mania. American Psychiatric Association Annual Meeting, San Francisco, CA, May 17-22.
5. Brecher M, Huizar K (2003) Quetiapine monotherapy for acute mania associated with bipolar disorder. Fifth International Conference on Bipolar Disorder, Pittsburgh, PA, June 12-14.
6. Calabrese JR, Kimmel SE, Woyshville MJ, Rapport DJ, Faust CJ, Thompson PA, Meltzer HY (1996) Clozapine for treatment-refractory mania. Am J Psychiatry, 153, 759-764.
7. Calabrese JR, Macfadden W, McCoy R, Minkwitz M, Wilson E, Mullen J (2004) Doubleblind, placebo-controlled study of quetiapine in bipolar depression. Abstracts of the American Psychiatric Association Annual Meeting, New York, NY, May 5, NR 756.
8. Ciapparelli A, Dell'Osso L, Pini S, Chiavacci MC, Fenzi M, Cassano GB (2000) Clozapine for treatment-refractory schizophrenia, schizoaffective disorder, and psychotic bipolar disorder: A 24-month naturalistic study. J Clin Psychiatry, 61, 329-334.
9. Ciapparelli A, Dell'Osso L, Bandettini di Poggio A, Carmassi C, Cecconi C, Fenzi M, Chiavacci MC, Bottai M, Ramaciotti CE, Cassano GB (2003) Clozapine in treatmentresistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: A naturalistic 48-month follow-up study. J Clin Psychiatry, 64, 451-458.
10. DelBello MP, Schwiers ML, Rosenberg HL, Strakowski SM (2002) A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry, 41, 1216-1223.
11. Frye MA, Ketter TA, Altshuler LL, Denicoff K, Dunn RT, Kimbrell TA, Cora-Locatelli G, Post RM (1998) Clozapine in bipolar disorder: Treatment implications for other atypical antipsychtoics. J Affect Disord, 48, 91-104.
12. Gerner RH, Post RM, Bunney WE (1976) A dopaminergic mechanism in mania. Am J Psychiatry, 133, 1177-1180.
13. Green AI, Tohen M, Patel JK, Banov M, DuRand C, Berman I, Chang H, Zarate C, Posener J, Lee H, Dawson R, Richards C, Cole JO, Schatzberg AF (2000) Clozapine in the treatment of refractory psychotic mania. Am J Psychiatry, 157, 982-986.
14. Hillert A, Maier W, Wetzel H (1992). Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome-a functional approach. Pharmacopsychiatry 25, 213-217.
15. Janicak PG, Keck PE, Jr, Davis JM, Kasckow JW, Tugrul KC, Dowd SM, Strong J, Sharma RP, Strakowski SM (2001). A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder. J Clin Psychopharmacol 21, 360-368.
16. Jones M, Huizar K (2003) Quetiapine monotherapy for mania associated with bipolar disorder. Fifth International Conference on Bipolar Disorder, Pittsburgh, PA, June 12-14.
17. Kapur S, Seeman P (2001) Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?: A new hypothesis. Am J Psychiatry, 158, 360-369.
18. Keck PE, Jr., McElroy SL (2003a) Redefining mood stabilization. J Affect Disord 73, 163-169.
19. Keck PE, Jr., McElroy SL (2003b) Aripiprazole: A partial dopamine D2 receptor agonist antipsychotic. Expert Opin Investig Drugs 12, 655-662.
20. Keck PE, Jr, Wilson DR, Strakowski SM (1994). Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. J Clin Psychiatry, 56, 466-470.
21. Keck PE, Jr., McElroy SL, Arnold LM (2001a) Ziprasidone: A new atypical antipsychotic. Expert Opin Pharmacother 2, 1033-1042.
22. Keck PE, Jr., McElroy SL, Strakowski SM, West SA (1994) Pharmacologic treatment of schizoaffective disorder. Psychopharmacology, 114, 529-538.
23. Keck PE, Jr., McElroy SL, Richtand N, Tohen M (2002) What makes a drug a primary mood stabilizer? Mol Psychiatry, 7 (Suppl.), s8-s14.
24. Keck PE, Jr., Nelson EB, McElroy SL (2003) Advances in the pharmacologic treatment of bipolar depression. Biol Psychiatry 53, 671-679.
25. Keck PE, Jr., Reeves KR, Harrigan EP, and the Ziprasidone Study Group (2001b) Ziprasidone in the short-term treatment of patients with schizoaffective disorder: Results from two double-blind, placebo-controlled trials. J Clin Psychopharmacol, 21, 27-35.
26. Keck PE, Jr., Versiana M, Potkin S, West SA, Giller E, Ice K (2003a) Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry, 160, 741-748.
27. Keck PE, Jr., Marcus R, Tourkodimitris S, Ali M, Liebeskind A, Saha A, Ingenito G, and the Aripiprazole Study Group (2003b) Am J Psychiatry, 160, 1651-1658.
28. Kimmel SE, Calabrese JR, Woyshville MJ, Meltzer HY (1994) Clozapine in treatmentrefractory mood disorders. J Clin Psychiatry, 55 (Suppl. B), 91-93.
29. Mahmood T, Devlin M, Silverstone T (1997) Clozapine in the management of bipolar and schizoaffective manic episodes resistant to standard treatment. Aust N Z J Psychiatry, 31, 424-426.
30. Marcus R, Carson WE, McQuade RD, Sanchez R, Iwamoto T, Stock E (2003) Long-term efficacy of aripiprazole in the maintenance treatment of bipolar disorder. Abstracts of the Annual Meeting of the American College of Neuropsychopharmacology, San Juan, PR, December 8-11.
31. McElroy SL, Keck PE, Jr. (2000) Pharmacologic agents for the treatment of acute bipolar mania. Biol Psychiatry, 48, 539-557.
32. McElroy SL, Dessain EC, Pope HG, Jr., Cole JO, Keck PE, Jr., Frankenberg FR, Aizely HG, O'Brien S (1991) Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry, 52, 411-414.
33. Mullen JA, Devine NA, Sweitzer DE (2003a) Quetiapine adjunctive therapy for mania associated with bipolar disorder. Fifth International Conference on Bipolar Disorder, Pittsburgh, PA, June 12-14.
34. Mullen JA, Paulsson B (2003b) Quetiapine in combination with lithium or divalproex for the treatment of mania associated with bipolar disorder. Fifth International Conference on Bipolar Disorder, Pittsburgh, PA, June 12-14.
35. Muller-Siecheneder F, Muller FJ, Hillert A (1998). Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome. J Clin Psychopharmacol 18, 111-120.
36. Paulsson B (2003) Quetiapine monotherapy for the treatment of bipolar mania. Fifth International Conference on Bipolar Disorder, Pittsburgh, PA, June 12-14.
37. Sajatovic M, Mullen JA, Sweitzer DE (2002) Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis. J Clin Psychiatry, 63, 1156-1163.
38. Segal S, Reisenberg RA, Ice K, English P (2003) Ziprasidone in mania: A double-blind, placebo-controlled trial. Abstracts of the Annual Meeting of the American College of Neuropsychopharmacolgy, San Juan, Puerto Rico, December 8-11.
39. Suppes T, McElroy SL, Gilbert J, Dessain EC, Cole JO (1992) Clozapine in the treatment of dysphoric mania. Biol Psychiatry, 32, 270-280.
40. Suppes T, Phillips KA, Judd CR (1994) Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: a report of three cases. Biol Psychiatry, 36, 338-340.
41. Suppes T, Webb A, Paul B, Carmody T, Kraemer H, Rush AJ (1999) Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatmentresistant illness and a history of mania. Am J Psychiatry, 156, 1164-1169.
42. Weisler RH Ziprasidone versus placebo in combination with lithium in acute mania. Abstracts of the European College of Neuropsychopharmacology Annual Meeting, September 2003.
43. Zarate CA, Tohen M, Baldessarini RJ (1995a) Clozapine in severe mood disorders. J Clin Psychiatry, 56, 411-417.
44. Zarate CA, Tohen M, Banov MD, Weiss MK, Cole JO (1995b) Is clozapine a mood stabilizer? J Clin Psychiatry, 56, 108-112.